Early Stage Hodgkin’s Lymphoma

Study Confirms that Radiation Therapy Is Not Necessary in Patients with Favorable, Limited-stage Hodgkin’s Lymphoma (04-6-2010)

Researchers from the Dana-Farber Cancer Center have confirmed prior studies that indicate chemotherapy alone is safe and effective for the treatment of early-stage Hodgkin’s Lymphoma in appropriate patients. The details of this study were published... Continue Reading

Study Confirms that Radiation Therapy Is Not Necessary in Patients with Favorable, Limited-stage Hodgkin’s Lymphoma (04-6-2010)

Researchers from the Dana-Farber Cancer Center have confirmed prior studies that indicate chemotherapy alone is safe and effective for the treatment of early-stage Hodgkin’s Lymphoma in appropriate patients. The details of this study were published... Continue Reading

Hodgkin’s Survivors at Increased Risk of Stroke (06-24-2009)

Hodgkin’s Survivors at Increased Risk of Stroke Patients who have been treated with radiation therapy for Hodgkin’s lymphoma have an elevated risk of stroke. These results were published in the Journal of the National Cancer Institute. Hodgkin’s... Continue Reading

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers (06-23-2009)

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers Industrial workers who are exposed to formaldehyde may be at an increased risk of dying from blood and lymphatic cancers, particularly myeloid leukemia but also Hodgkin’s lymphoma... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas (03-8-2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies... Continue Reading

Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma (03-8-2009)

Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma A recent study compared lymphocyte-predominant Hodgkin’s lymphoma (LPHL) and classical Hodgkin’s lymphoma (cHL) in order to define differences in patient characteristics... Continue Reading

Hodgkin’s Lymphoma Survivors May Be at Risk for Secondary Cancer (03-8-2009)

Hodgkin’s Lymphoma Survivors May Be at Risk for Secondary Cancer Hodgkin’s lymphoma survivors may be at risk for secondary cancer. These findings were recently reported in the British Journal of Cancer. Hodgkin’s lymphoma is a cancer... Continue Reading

The American Society of Clinical Oncology 2008: Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia (03-8-2009)

The American Society of Clinical Oncology 2008: Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia At the 2008 meeting of the American Society of Clinical Oncology (ASCO), there were more than 100 abstracts devoted to the treatment of... Continue Reading

Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors (03-8-2009)

Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors According to the results of a study published in the Annals of Oncology, annual screening mammography may miss some cases of early invasive breast cancer among young Hodgkin’s... Continue Reading

Hodgkin’s Survivors: Increased Fatigue, Cardiac, and Thyroid Complications (02-5-2009)

According to an article published in the Annals of Oncology, survivors of Hodgkin’s lymphoma have a significantly increased rate of cardiac and thyroid complications than their siblings. In addition, survivors tend to have more fatigue than their siblings;... Continue Reading

« Previous PageNext Page »